Download Free Sample Report

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.
This report contains market size and forecasts of Medical Viscosupplementation Injection in global, including the following market information:

• Global Medical Viscosupplementation Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global Medical Viscosupplementation Injection Market Sales, 2018-2023, 2023-2030, (Units)
• Global top five Medical Viscosupplementation Injection companies in 2022 (%)

The global Medical Viscosupplementation Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Single Injection Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Medical Viscosupplementation Injection include Sanofi, Anika Therapeutics, Seikagaku, Zimmer Biomet, Bioventus, Ferring, LG Chem, Freda and Haohai Biological and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Viscosupplementation Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Viscosupplementation Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, by Type, 2022 (%)

• Single Injection
• Three Injection
• Five Injection

Global Medical Viscosupplementation Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, by Application, 2022 (%)

• Hospital
• Clinic
• Other

Global Medical Viscosupplementation Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Viscosupplementation Injection Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Medical Viscosupplementation Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Medical Viscosupplementation Injection revenues share in global market, 2022 (%)
• Key companies Medical Viscosupplementation Injection sales in global market, 2018-2023 (Estimated), (Units)
• Key companies Medical Viscosupplementation Injection sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Anika Therapeutics
• Seikagaku
• Zimmer Biomet
• Bioventus
• Ferring
• LG Chem
• Freda
• Haohai Biological
• Shanghai Jingfeng